Yangyang Yu Selected Research

Yangyang Yu Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 08/2016
6	type 2C Congenital disorder of glycosylation 10/2022 - 01/2014
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 12/2021
4	Hypoxia (Hypoxemia) 12/2022 - 04/2019
4	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2020
3	Inflammation (Inflammations) 08/2022 - 01/2018
2	Triple Negative Breast Neoplasms 04/2024 - 08/2016
2	Endometriosis 01/2023 - 10/2022
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 04/2018
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 12/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2018
2	Retinoblastoma (Glioblastoma, Retinal) 01/2018 - 07/2017
2	Cardiotoxicity 06/2017 - 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 05/2024
1	Poisoning 05/2024
1	Dental Fluorosis 04/2024
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2023
1	Congenital Diaphragmatic Hernias 12/2023
1	Thrombosis (Thrombus) 11/2023
1	Necrosis 03/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Exanthema (Rash) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Intussusception 12/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 12/2022
1	Melanoma (Melanoma, Malignant) 09/2022

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 04/2024 - 06/2016
4	Interleukin-8 (Interleukin 8)IBA 10/2022 - 06/2016
3	Phosphotransferases (Kinase)IBA 04/2024 - 12/2022
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2019
3	CytokinesIBA 05/2022 - 12/2015
3	anti-IgE antibodiesIBA 05/2022 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 11/2022
2	CalciumIBA 04/2024 - 10/2022
2	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 01/2018
2	Eosine Yellowish-(YS) (Eosin)IBA 04/2024 - 03/2023
2	Hematoxylin (Haematoxylon)IBA 04/2024 - 03/2023
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2022
2	Substance PIBA 10/2022 - 06/2016
2	Circulating Tumor DNAIBA 01/2022 - 01/2021
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021 - 01/2018
2	Messenger RNA (mRNA)IBA 01/2020 - 08/2016
2	Toll-Like Receptor 2IBA 01/2020 - 12/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 01/2018 - 07/2017
2	CurcuminIBA 01/2018 - 01/2018
2	Endothelin A ReceptorIBA 01/2018 - 08/2016
2	Endothelin-1 (Endothelin 1)IBA 01/2018 - 08/2016
1	AntioxidantsIBA 05/2024
1	Acetylcysteine (Siran)FDA LinkGeneric 05/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024
1	CCAAT-Enhancer-Binding Protein-deltaIBA 04/2024
1	Vesicle-Associated Membrane Protein 3IBA 04/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2024
1	Inositol (Myoinositol)IBA 04/2024
1	Activating Transcription Factor 6IBA 04/2024
1	CalreticulinIBA 04/2024
1	T16AInh-A01IBA 04/2024
1	Endoplasmic Reticulum Chaperone BiPIBA 04/2024
1	FluoridesIBA 04/2024
1	Interleukin-6 (Interleukin 6)IBA 03/2023
1	Toll-Like Receptor 4IBA 03/2023
1	ImmunosorbentsIBA 03/2023
1	Myeloid Differentiation Factor 88IBA 03/2023
1	InterleukinsIBA 03/2023
1	EnzymesIBA 03/2023
1	CrizotinibIBA 01/2023
1	tislelizumabIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	ensartinibIBA 01/2023
1	Capsules (Microcapsules)IBA 12/2022
1	Activating Transcription Factor 4IBA 12/2022
1	Alizarin Red SIBA 12/2022
1	Protein Kinases (Protein Kinase)IBA 12/2022
1	Immunotoxins (Immunotoxin)IBA 11/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2022
1	Coloring Agents (Dyes)IBA 11/2022
1	Single-Domain AntibodiesIBA 11/2022
1	Cadherins (E-Cadherin)IBA 11/2022
1	N-methyladenosineIBA 10/2022
1	Indicators and Reagents (Reagents)IBA 09/2022
1	Immune Checkpoint InhibitorsIBA 09/2022
1	LipopolysaccharidesIBA 08/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 05/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 05/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2022
1	6-O-angeloylprenolinIBA 05/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 05/2022
1	AllergensIBA 01/2022

Therapy/Procedure

4	Immunotherapy 12/2022 - 08/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
3	Chemoradiotherapy 01/2021 - 01/2020
2	Neoadjuvant Therapy 01/2022 - 01/2020
2	Aftercare (After-Treatment) 01/2022 - 07/2017
1	Extracorporeal Membrane Oxygenation 12/2023
1	Embolic Protection Devices 11/2023
1	Therapeutics 01/2023
1	Conservative Treatment 12/2022